Roundup: Pfizer finalises ResApp acquisition and more briefs

0
52



Pfizer completes ResApp buy for over $115 million

Biopharmaceutical large Pfizer has finalised its acquisition of ASX-listed digital well being startup ResApp for A$179 million ($116 million), in keeping with the College of Queensland.

Brisbane-based ResApp has developed a cell app that analyses cough sounds and diagnoses respiratory illnesses, together with bronchial asthma, pneumonia, bronchiolitis, croup and continual obstructive pulmonary illness. The corporate additionally not too long ago demonstrated the aptitude of its app to diagnose COVID-19. 

Authorized to be used in Australia and Europe, ResAppDx may be built-in with telehealth platforms, emergency departments, and first care settings.


New NHMRC-backed centre to use AI in breast most cancers threat classification

A risk-based strategy utilizing AI might be utilized to a brand new breast most cancers screening centre launched on the College of Melbourne.

Supported by the Nationwide Well being and Medical Analysis Council (NHMRC), Australia’s major statutory authority for medical analysis, the My Breast Most cancers RISK Centre (MyBRISK) will use AI to analyse tens of millions of mammograms to determine “extra highly effective mammogram-based threat components.”

These automated measures, mixed with household historical past, life-style and gene exams, will allow testing to raised classify ladies of all ages by way of their breast most cancers threat, the college mentioned in a media launch.

As current breast most cancers threat evaluation instruments are mentioned to be “cumbersome and lack precision,” this new NHMRC Centre for Analysis Excellence goals to “create pathways for more practical personalised screening.”

MyBRISK is a collaboration between the College of Melbourne, Melbourne’s St Vincent’s Hospital, Monash College, College of Western Australia, Queensland College of Know-how and Most cancers Council Victoria.


Digital software reduces remedy errors in kids’s hospitals: analysis

New analysis in Sydney has demonstrated how the usage of an digital remedy administration system (eMeds) might help decrease remedy errors in kids’s hospitals.

Performed by Macquarie College, Sydney Kids’s Hospital and eHealth NSW, the examine concerned the assessment of greater than 43,000 remedy orders for about 8,000 paediatric sufferers.

eMeds, which is now utilized in 200 hospitals throughout New South Wales to prescribe, dispense, and supply drugs to sufferers, was developed by eHealth NSW. The know-how additionally helps monitor interactions and doses and offers security alerts to keep away from errors.


Townsville College Hospital implements Dell’s information storage options 

Townsville College Hospital (TUH), a tertiary referral hospital in northern Queensland, has deployed information storage options from Dell Applied sciences to reinforce data sharing and care high quality. 

Based on a press launch, the hospital has adopted Dell PowerStore, a single storage platform that gives block-based storage and a centralised information lake. It has change into the muse of its ward administration and affected person movement reporting methods, leading to “important development” in medical media and has enabled employees to carry out close to real-time reporting as a substitute of batch processing.

TUH additionally applied Dell PowerScale, which offers a single repository for unstructured information. 

“Collectively, the brand new storage options present TUH with further efficiency, improved redundancy, scalability and adaptability,” Dell mentioned in a press release.

LEAVE A REPLY

Please enter your comment!
Please enter your name here